Abstract
Surgery is a highly effective treatment for some specific types of refractory epilepsy and once seizure freedom is achieved many patients and clinicians have to ponder whether to taper or discontinue antiepileptic drugs (AEDs). However, there is no standard practice or guidelines and practices vary widely. The few studies that have addressed this question are retrospective and lack randomised, controlled comparisons, making it difficult to draw any solid inferences. This review examines this topic by analysing key data based on the following: controlled studies which compare outcomes in patients with either withdrawn or unmodified AEDs after epilepsy surgery, non-controlled studies, information from meta-analyses and systematic reviews, surveys of clinical practice, and other relevant reviews. Between 12 and 32% of patients had seizure relapse following tapering or discontinuation of AEDs, which was not significantly different from 7 to 45% in patients without AED modification. In the event of seizure relapse upon tapering of AEDs, 45–92.3% restarted AED treatment and regained seizure freedom. The most consistent risk factors for seizure relapsewere: age older than 30 years at the time of surgery, persistent auras, early drug tapering, seizure recurrence before a reduction of drugs, normal MRI, a longer period with epilepsy, absence of hippocampal sclerosis, and the presence of interictal discharges on EEG after surgery.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Berg AT. Stopping antiepileptic drugs after successful surgery: what do we know? And what do we still need to learn? Epilepsia 2004; 45: 101–102.
Berg AT, Vickrey BG, Langfitt JT, et al. Reduction of AEDs in postsurgical patients who attain remission. Epilepsia 2006; 47: 64–71.
Berg AT, Langfitt JT, Spencer SS, Vickrey BG. Stopping antiepileptic drugs after epilepsy surgery: a survey of US epilepsy center neurologists. Epilepsy Behav 2007; 10: 219–222.
de Tisi J, Bell GS, Peacock JL, et al. The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet 2011; 378: 1388–1395.
Engel J Jr, Wiebe S, French J, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 2003; 60: 538–547.
Griffin CT, Abastillas ME, Armon C, et al. Early antiepileptic drug reduction following anterior temporal lobectomy for medically intractable complex partial epilepsy. Seizure 2004; 13: 434–437.
Kerling F, Pauli E, Lorber B, Blumcke I, Buchfelder M, Stefan H. Drug withdrawal after successful epilepsy surgery: how safe is it? Epilepsy Behav 2009; 15: 476–480.
Kim YD, Heo K, Park SC, et al. Antiepileptic drug withdrawal after successful surgery for intractable temporal lobe epilepsy. Epilepsia 2005; 46: 251–257.
Kuzniecky R, Rubin ZK, Faught E, Morawetz R. Antiepileptic drug treatment after temporal lobe epilepsy surgery: a randomized study comparing carbamazepine and polytherapy. Epilepsia 1992; 33: 908–912.
Lee SY, Lee JY, Kim DW, Lee SK, Chung CK. Factors related to successful antiepileptic drug withdrawal after anterior temporal lobectomy for medial temporal lobe epilepsy. Seizure 2008; 17: 11–18.
McLachlan RS, Maher J. Management of antiepileptic drugs following epilepsy surgery: a review. Can J Neurol Sci 2000; 27: S106–S110.
Park KI, Lee SK, Chu K, et al. Withdrawal of antiepileptic drugs after neocortical epilepsy surgery. AnnNeurol 2010; 67: 230–238.
Rathore C, Panda S, Sarma PS, Radhakrishnan K. How safe is it to withdraw antiepileptic drugs following successful surgery for mesial temporal lobe epilepsy? Epilepsia 2011; 52: 627–635.
Schiller Y, Cascino GD, So EL, Marsh WR. Discontinuation of antiepileptic drugs after successful epilepsy surgery. Neurology 2000; 54: 346–349.
Schmidt D, Loscher W. How effective is surgery to cure seizures in drug-resistant temporal lobe epilepsy? Epilepsy Res 2003; 56: 85–91.
Schmidt D, Baumgartner C, Loscher W. The chance of cure following surgery for drug-resistant temporal lobe epilepsy. What doweknowand dowe need to revise our expectations? Epilepsy Res 2004; 60: 187–201.
Spencer S, Huh L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol 2008; 7: 525–537.
Tellez-Zenteno JF, Dhar R, Hernandez-Ronquillo L, Wiebe S. Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects. Brain 2007; 130: 334–345.
Tellez-Zenteno JF, Ronquillo LH, Jette N, et al. Discontinuation of antiepileptic drugs after successful epilepsy surgery. A Canadian survey. Epilepsy Res 2012. In press.
Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal lobe epilepsy. N Engl J Med 2001; 345: 311–318.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Tellez-Zenteno, J.F., Hernandez-Ronquillo, L. & Moien-Afshari, F. Discontinuation of antiepileptic drugs after successful surgery: who and when?. Epileptic Disord. 14, 363–370 (2012). https://doi.org/10.1684/epd.2012.0538
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1684/epd.2012.0538